Transient Tachypnea of the Newborn

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/16

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

17 Terms

1
New cards

Transient Tachypnea of the Newborn (TTN)

A self-limiting condition involving mild respiratory distress caused by delayed clearance of fetal lung liquid.

2
New cards

Pathophysiology of TTN

Occurs when fetal lung fluid is removed slowly or incompletely, leading to pulmonary edema and decreased lung compliance.

3
New cards

Incidence of TTN

Occurs in approximately 1% of live term births, with a higher incidence in males.

4
New cards

TTN Symptoms

Tachypnea, grunting, intercostal retractions, decreased breath sounds, labored breathing, nasal flaring, crackles, and mild cyanosis.

5
New cards

Evaluation period for TTN

Symptoms generally resolve within 48-72 hours after birth.

6
New cards

Laboratory Diagnosis for TTN

Chest x-ray typically shows mild symmetric lung hyperaeration and prominent perihilar markings.

7
New cards

Respiratory Distress Syndrome (RDS)

A condition resulting from developmental deficiency in surfactant synthesis, leading to lung immaturity and hypoperfusion.

8
New cards

Surfactant Role in RDS

Surfactant prevents alveolar collapse and allows for easy lung inflation; its deficiency leads to compromised lung expansion.

9
New cards

RDS Prevalence

Affects up to 25,000 infants born alive in the United States annually, especially preterm infants.

10
New cards

Signs of RDS

Expiratory grunting, shallow breathing, nasal flaring, tachycardia, and general cyanosis are common symptoms at birth.

11
New cards

Diagnosis of RDS

Based on clinical picture, lung ultrasound, chest x-ray, and arterial blood gases showing hypoxemia and acidosis.

12
New cards

Management Focus for RDS

Supportive care until surfactant is produced, which includes maintaining oxygenation and lung volumes.

13
New cards

Surfactant Replacement Therapy

Crucial treatment for RDS that stabilizes the infant's lungs until postnatal surfactant synthesis matures.

14
New cards

Contradictions in RDS Management

Oxygen administration and ventilation practices may not always be evidence-based and require careful consideration.

15
New cards

Role of Prenatal Steroids

A single course of prenatal steroids helps reduce the incidence of RDS but the effects of repeated courses remain unclear.

16
New cards

Signs of Improving TTN

Decline in respiratory rate to 60 breaths/min or less; resolution of cyanosis, nasal flaring, and grunting.

17
New cards

Supportive Interventions for Newborns with RDS

Includes monitoring vital signs, providing adequate hydration and nutrition, maintaining warmth, and encouraging parental participation in care.